TRIP13: A promising cancer immunotherapy target
Open Access
- 11 October 2024
- journal article
- review article
- Published by Wiley in Cancer Innovation
- Vol. 3 (6) , e147
Abstract
The tumor microenvironment (TME) facilitates tumor development through intricate intercellular signaling, thereby supporting tumor growth and suppressing the immune response. Thyroid hormone receptor interactor 13 (TRIP13), an AAA+ ATPase, modulates the conformation of client macromolecules, consequently influencing cellular signaling pathways. TRIP13 has been implicated in processes such as proliferation, invasion, migration, and metastasis during tumor progression. Recent studies have revealed that TRIP13 also plays a role in immune response suppression within the TME. Thus, inhibiting these functions of TRIP13 could potentially enhance immune responses and improve the efficacy of immune checkpoint inhibition. This review summarizes the recent research progress of TRIP13 and discusses the potential of targeting TRIP13 to improve immune‐based therapies for patients with cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82100557)
This publication has 83 references indexed in Scilit:
- Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell ProliferationThe Journal of Immunology, 2002
- Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and AutoimmunityThe Journal of Immunology, 1999
- Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.1999
- Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesisGenes & Development, 1999
- Pch2 Links Chromatin Silencing to Meiotic Checkpoint ControlCell, 1999
- The Dendritic Cell System and its Role in ImmunogenicityAnnual Review of Immunology, 1991
- SUPPRESSION OF PULMONARY TUMOR-METASTASIS IN MICE BY RECOMBINANT HUMAN INTERLEUKIN-2 - ROLE OF ASIALO GM1-POSITIVE CELLS1987
- Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: Correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastasesInternational Journal of Cancer, 1984
- Susceptibility of Various Strains of Mice to Urethan-Induced Lung Tumors and Depressed Natural Killer Cell Activity2JNCI: Journal of the National Cancer Institute, 1981
- In vivo anti-tumor effects of local adoptive transfer of mouse and human cultured lymphoid cellsInternational Journal of Cancer, 1981